MimiVax Inc.
PrivateLast Round
Debt
Jul 16, 2024
Total Funding Raised
$10M
Company Overview
MimiVax Inc. operates in Healthcare & Life Sciences and is based in Buffalo, New York. Its latest recorded funding round was a VC Round in January 2024.
MimiVax Inc. is a biotechnology company that develops immunotherapeutic vaccines and targeted therapies designed to control tumor growth and recurrence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MimiVax Inc. Comparables
Compare MimiVax Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imvax | 82% | |
| iOncologi | 80% | |
| Diakonos Oncology | 80% |
For institutional investors. Book with your work email.
MimiVax Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 16, 2024 | ||||
| VC Round | Jan 9, 2024 | ||||
| Corporate Funding | Nov 18, 2019 | ||||
| Grant | Jan 1, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MimiVax Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MEDA Angels | VC Round |
| Varia Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 39% MoM.
- May 16, 2026
Monthly visitors increased 270% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 9, 2026
MimiVax, Inc. partners with Roswell Park on a phase 2 trial evaluating SurVaxM with temozolomide in patients with progressing neuroendocrine tumors, announced in New York on May 5th '26.
For institutional investors. Book with your work email.
MimiVax Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MimiVax Inc.'s valuation, stock price, and market status.
Is MimiVax Inc. a public or private company?
MimiVax Inc. is a private company.
What is the current stock price of MimiVax Inc.?
MimiVax Inc. is a private company, so its shares have no public market price. Caplight tracks MimiVax Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MimiVax Inc. worth (valuation)?
Valuation information for MimiVax Inc. is not publicly available.
Can I buy MimiVax Inc. stock?
MimiVax Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MimiVax Inc.'s last funding round?
MimiVax Inc.'s most recent funding round was Debt on July 16, 2024.
Who are the main investors in MimiVax Inc.?
Key investors in MimiVax Inc. include MEDA Angels, Varia Ventures.
Will MimiVax Inc. IPO soon?
No public IPO plans have been announced for MimiVax Inc..
How can I track MimiVax Inc. secondary market activity?
Caplight tracks bids, offers, and trades in MimiVax Inc.'s shares on secondary markets.